key: cord-0053016-drdi2to3
authors: Kumar, Amit; Saxena, Ajit Kumar; Lee, Gwo Giun (Chris); Kashyap, Amita; Jyothsna, G.
title: COVID19 Rapid Diagnostic Kits
date: 2020-09-27
journal: Novel Coronavirus 2019
DOI: 10.1007/978-981-15-7918-9_10
sha: 19249973ce1bdca2ec7a5fe0b7677ca2b07c61b2
doc_id: 53016
cord_uid: drdi2to3

Apart from the treatment options, protocols and preventive measures against COVID, an essential step prior to the treatment is its quick and accurate diagnosis. There are several diagnostic protocols prevailing currently for the identification of COVID infection. The Gold standard available diagnosis is based on the identification of pathogen by RTPCR analysis [1]. This involves extraction of the genetic material of the virus followed by its amplification using specific primers and identification.

LabCorp COVID-19 RT-PCR test Kit is one of the most widely accepted kits because of its authenticity and validity. This kit is EUA [3] ie Accelerated Emergency Use Authorization kit. The kit is based on the RT PCR analysis of the Clinical specimens that are obtained from the nasal and throat swabs. This RT PCR based test kit performs the qualitative detection of nucleic acids from the upper and lower respiratory specimen of SARS CoV 2. Some of the specimen used for testing includes nasopharyngeal sample, oropharyngeal swabs, aspirates from lower respiratory tract, sputum, bronchoalveolar lavage and nasopharyngeal aspirate. The test conducted by this kit involves the use of 3 primers and their probes to identify three different regions in the SARS CoV genome which is the Nucleocapsid N gene. One of the three sets is used to identify the Human RNase P or RP in the clinical specimen. The initial step in the protocol is the isolation of the genomic RNA from the pathogen within the specimen. This is followed by its purification and amplification. Applied Biosystems QuantStudio7 Flex (QS7) instrument with 1.3 version of the software is used for the amplification of the sample. During the PCR cycle there is an annealing step where the probe binds to the specific region in the target sequence between both forward and reverse primers. The bound probe is later degraded by the Taq Polymerase enzyme during the extension phase of the PCR cycle. This reaction can be detected using the reporter dye FAM which gets separated from the quencher dye BHQI which generates a fluorescent signal. The intensity of this fluorescence is detected during each cycle using QS7. Before the interpretation of results for the patient samples all the controls have to be examined to determine the accuracy of the protocol.

The protocol involves the use of Roche MagNA Pure-96 (MP96) kit for the extraction along with the Applied Biosystems QuantStudio7 Flex (QS7) instrument with software version 1.3 (Fig. 10.1) .

Some important components in the kit are as follows (1) To eliminate the chances of errors due to sample contamination, a negative control which is molecular level nuclease free water is used in each plate of the assay. (2) A positive template of COVID-19 that contains in vitro transcribed pure viral targeted RNA with one copy each of N1, N2 and N3 is added during the addition of master mix at a concentration of copies/uL. This is also added to each of the assay plates. (3) To confirm the presence of nucleic acid in the sample an internal Hs_RPP30 control targeting RNase P is used. This is an extraction control. (4) An NEC (Negative extraction control) obtained from previous testing is used for the negative patient sample confirmation (Fig. 10.2 ).

RAPID test kits involve the identification of antibodies in the blood or other specimen samples based on their binding to the test antigens added in the test. The tests are mostly based on the lateral flow qualitative immune-chromatographic assay [4]. The results are read based on the development of a colored line similar to the HCG detection kit. The targeted antibodies are Immunoglobulin M-IgM, and Immunoglobulin G-IgG in the samples like blood, serum or plasma. The results in this test can be visually analyzed and obtained within a time frame of 10 min. Best approach in emergencies and is a cost effective method for diagnosis. Most of the available RAPID test kits available globally are designed with a sample pad and a chromatographic membrane, mostly a nitrocellulose membrane that is coated with mouse anti-human Immunoglobulin M monoclonal antibody and a mouse anti-human IgG monoclonal antibody and goat anti-mouse IgG antibody. It also has a colloidal binding pad coated with labeled recombinant novel coronavirus (COVID-19) antigen and mouse IgG antibody, a liner and an absorbent pad [5] . The results are detected based on the development of colored lines on the chromatographic strip. Unfortunately, Rapid testing kits against COVID 19 has not been a great success as of now, higher percentage of false positive and false negative results have been confusing the diagnosis. It is not considered a standard approach, Governments and Authorities have been recommending getting the RT PCR testing done even if someone has tested negative with Rapid kits in COVID Cases.

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

COVID-19) Novel coronavirus (2019-nCoV) real-time RT-PCR primers and probes. Centre for Disease Control and Prevention

COVID-19 IgG/IgM Rapid Test Kit